Turning Point Therapeutics Company

Turning Point Therapeutics, Inc. is a clinical-stage structure-based drug design company for the discovery and development of precision medicines for cancer and other diseases. We are focusing on the design of novel chemical identities for established oncogene drivers with secondary resistant mutations, newly identified disease-driven targets, and potential targets regulating tumor microenvironment and tumor immunity.
Technology: P4 Medicine
Industry: Biotechnology, Health Care, Pharmaceutical, Therapeutics
Headquarters: San Diego, California, United States
Founded Date: 2013-10-08
Employees Number: 51-100
Funding Status: IPO
Investors Number: 11
Total Funding: $720.7M
Estimated Revenue: $50M to $100M
Last Funding Type: Post-IPO Equity

Visit Website
peter.li@tptherapeutics.com
https://twitter.com/TPTherapeutics
Register and Claim Ownership